US 10001485
Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor
granted A61KA61K31/166A61K31/506
Quick answer
US patent 10001485 (Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor) held by The Regents of the University of California expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/166, A61K31/506, A61K45/06